Company: ADZCF
Filing Date: 2025-06-18
Form Type: 424B2
Source: 0000950103-25-007590
Chunk: 23

Company: DEUTSCHE BANK AKTIENGESELLSCHAFT
Filing Date: 2025-06-18
Form: 424B2
Chunk 23
---
 Our determination is not binding on the IRS, and the IRS may disagree with this determination. If necessary, further
information regarding the potential application of Section 871(m) will be provided in the final pricing supplement for the Notes.

We will not be required to pay any additional amounts with respect to
U.S. federal withholding taxes.

You should read the section entitled “U.S. Federal Income Tax
Consequences” in the accompanying product supplement. The preceding discussion, when read in combination with that section, constitutes
the full opinion of our special tax counsel regarding the material U.S. federal income tax consequences of owning and disposing of the
Notes. You should also consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the Notes, as well
as tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.

For a discussion of certain German tax considerations
relating to the Notes, you should refer to the section in the accompanying prospectus supplement entitled “Taxation by Germany of
Non-Resident Holders.”

<div align='center'>PS-16</div>

| Comparable Yield and Projected Payment Schedule |

We will determine the comparable yield for the Notes and will provide
that comparable yield, and the projected payment schedule, or information about how to obtain them, in the final pricing supplement for
the Notes.

Neither the comparable yield nor the projected payment schedule constitutes
a representation by us regarding the actual amount(s) that we will pay on the Notes.

<div align='center'>PS-17</div>

| Supplemental Plan of Distribution (Conflicts of Interest) |

UBS Financial Services Inc. and its affiliates,
and DBSI, acting as agents for Deutsche Bank AG, will receive or allow as a concession or reallowance to other dealers discounts and commissions
in the amount indicated on the cover hereof. We will agree that UBS Financial Services Inc. may sell all or part of the Notes that it
purchases from us to investors at the price to public indicated on the cover of this pricing supplement, or to its affiliates at the price
to public indicated on the cover of this pricing supplement minus a concession not to exceed the discounts and commissions indicated on
the cover.

We or our affiliates expect to hedge our exposure from the Notes by entering into equity and equity derivative transactions, such as over-the-counter options, futures or exchange-traded instruments with one or more hedge counterparties, which will include UBS or its affiliates. The agent’s